Health · 1 sources covering this

Martin Kulldorff critiques scientific gatekeepers at NIH lecture

Martin Kulldorff, the biostatistician who advocated against Covid lockdowns, insisted that the rise in measles cases is caused by a widely disputed claim about said lockdowns:

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
Martin Kulldorff critiques scientific gatekeepers at NIH lecture
Martin Kulldorff, the biostatistician who advocated against Covid lockdowns, insisted that the rise in measles cases is caused by a widely disputed claim about said lockdowns:
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/13240e2b379be79f99762ce2f963bbad89f05df0"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Martin Kulldorff critiques scientific gatekeepers at NIH lecture"></iframe>

Martin Kulldorff critiques scientific gatekeepers at NIH lecture

How 1 sources are covering this

Martin Kulldorff critiques scientific gatekeepers at NIH lecture

More from Health

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

STAT+: Vertex kidney disease drug scrutinized for infection risk

STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more

STAT+: New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous

Reader

Trust & legal

Across the network

How 1 sources are covering this

Martin Kulldorff critiques scientific gatekeepers at NIH lecture

More from Health

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

STAT+: Vertex kidney disease drug scrutinized for infection risk

STAT+: Pharmalittle: We&#8217;re reading about a new policy for compounding peptides, a PBM disclosure rule, and more

STAT+: New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more